Transcription of ICH Topic Q 3 A Impurities Testing Guideline: …
{{id}} {{{paragraph}}}
Example: bankruptcy
ICH Topic Q 3 A Impurities Testing Guideline: …
The European Agency for the Evaluation of Medicinal ProductsHuman Medicines Evaluation UnitICH - Technical Coordination - R. Bass7 Westferry Circus, Canary Wharf, London E14 4HB, UKTel: (+44-171) 418 84 11 Fax: (+44-171) 418 85 51E_Mail: Topic Q 3 AImpurities Testing Guideline: Impurities in New DrugSubstancesStep 5 NOTE FOR GUIDANCE ON Impurities Testing : Impurities IN NEW DRUG SUBSTANCES (CPMP/ICH/142/95)APPROVAL BY CPMPMay 1995 DATE FOR COMING INTO OPERATION(STUDIES COMMENCING AFTER)1 November 1995 CPMP/ICH/142/951/11 Impurities IN NEW DRUG SUBSTANCESICH Harmonised Tripartite GuidelineTABLE OF of Impurities for the Reporting and Control of Impurities Organic Impurities Inorganic Impurities Solvents Impurity Content of Batches Limits for Impurities of Impurities Impurities I - "Decision Tree for Safety Studies 10 CPMP/ICH/142/952/11 Impurities IN NEW DRUG SUBSTANCESICH Harmonised Tripartite Guideline[EMEA Status as of May 1995] document is int
CPMP/ICH/142/95 2/11 IMPURITIES IN NEW DRUG SUBSTANCES ICH Harmonised Tripartite Guideline [EMEA Status as of May 1995] 1. PREAMBLE This document is intended to provide guidance for registration applications on the content and
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: